Microbiota are critical for vascular physiology: Germ-free status weakens contractility and induces sex-specific vascular remodeling in mice.


Journal

Vascular pharmacology
ISSN: 1879-3649
Titre abrégé: Vascul Pharmacol
Pays: United States
ID NLM: 101130615

Informations de publication

Date de publication:
Historique:
received: 23 09 2019
revised: 25 11 2019
accepted: 10 12 2019
pubmed: 18 12 2019
medline: 21 10 2020
entrez: 18 12 2019
Statut: ppublish

Résumé

Commensal microbiota within a holobiont contribute to the overall health of the host via mutualistic symbiosis. Disturbances in such symbiosis is prominently correlated with a variety of diseases affecting the modern society of humans including cardiovascular diseases, which are the number one contributors to human mortality. Given that a hallmark of all cardiovascular diseases is changes in vascular function, we hypothesized that depleting microbiota from a holobiont would induce vascular dysfunction. To test this hypothesis, young mice of both sexes raised in germ-free conditions were examined vascular contractility and structure. Here we observed that male and female germ-free mice presented a decrease in contraction of resistance arteries. These changes were more pronounced in germ-free males than in germ-free females mice. Furthermore, there was a distinct change in vascular remodeling between males and females germ-free mice. Resistance arteries from male germ-free mice demonstrated increased vascular stiffness, as shown by the leftward shift in the stress-strain curve and inward hypotrophic remodeling, a characteristic of chronic reduction in blood flow. On the other hand, resistance arteries from germ-free female mice were similar in the stress-strain curves to that of conventionally raised mice, but were distinctly different and showed outward hypertrophic remodeling, a characteristic seen in aging. Interestingly, we observed that reactive oxygen species (ROS) generation from bone marrow derived neutrophils is blunted in female germ-free mice, but it is exacerbated in male germ-free mice. In conclusion, these observations indicate that commensal microbiota of a holobiont are central to maintain proper vascular function and structure homeostasis, especially in males.

Identifiants

pubmed: 31843471
pii: S1537-1891(19)30279-4
doi: 10.1016/j.vph.2019.106633
pmc: PMC7036036
mid: NIHMS1064728
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

106633

Subventions

Organisme : NIGMS NIH HHS
ID : R00 GM118885
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL143082
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA219144
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Références

Cell. 2018 Oct 18;175(3):679-694.e22
pubmed: 30340040
Physiol Genomics. 2015 Jun;47(6):187-97
pubmed: 25829393
J Physiol. 2015 Jun 15;593(12):2547-9
pubmed: 26095019
Hypertension. 1996 Sep;28(3):505-6
pubmed: 8794840
Science. 2013 Mar 1;339(6123):1084-8
pubmed: 23328391
Med Biol Eng Comput. 2008 May;46(5):461-7
pubmed: 18228071
Blood Vessels. 1990;27(2-5):246-57
pubmed: 2242445
Circ Res. 2017 Jan 20;120(2):312-323
pubmed: 27799253
Physiol Genomics. 2018 Oct 1;50(10):837-845
pubmed: 30095376
Clin Sci (Lond). 2018 Mar 30;132(6):701-718
pubmed: 29507058
Cell. 2016 Jan 28;164(3):337-40
pubmed: 26824647
J Exp Med. 1971 Oct 1;134(4):846-56
pubmed: 4329047
Cardiovasc Res. 2008 May 1;78(2):274-85
pubmed: 18250145
Science. 2013 Sep 6;341(6150):1241214
pubmed: 24009397
Nature. 2017 Nov 30;551(7682):585-589
pubmed: 29143823
J Am Heart Assoc. 2018 Feb 16;7(4):
pubmed: 29453308
Pharmacol Res. 2019 Mar;141:276-290
pubmed: 30639374
Nat Rev Cardiol. 2019 Mar;16(3):137-154
pubmed: 30410105
Infect Immun. 1971 Feb;3(2):342-9
pubmed: 16557975
Circ Res. 2017 Jan 20;120(2):249-251
pubmed: 28104760
Am J Hypertens. 2018 Sep 11;31(10):1067-1078
pubmed: 29788246
Cell Metab. 2015 Dec 1;22(6):983-96
pubmed: 26525535
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):696-706
pubmed: 17634315
Symbiosis. 1991;11:93-101
pubmed: 11538111
Am J Physiol. 1959 Dec;197:1345-6
pubmed: 13846013
Eur J Nutr. 2002 Nov;41 Suppl 1:I32-7
pubmed: 12420114
J Hypertens. 2014 Mar;32(3):542-54
pubmed: 24309491
Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R341-4
pubmed: 16166211
Mol Psychiatry. 2013 Jun;18(6):666-73
pubmed: 22688187
Front Cell Infect Microbiol. 2017 Aug 25;7:373
pubmed: 28890882
Curr Hypertens Rep. 2017 Apr;19(4):35
pubmed: 28365886
Neurogastroenterol Motil. 2014 Jun;26(6):745-8
pubmed: 24860967
J Am Heart Assoc. 2016 Aug 30;5(9):
pubmed: 27577581
Acta Physiol (Oxf). 2014 Feb;210(2):307-16
pubmed: 24268043
Kidney Int. 2016 Dec;90(6):1191-1198
pubmed: 27575555
Exp Physiol. 2016 Feb;101(2):230-42
pubmed: 26663420
Hypertension. 2018 Jul;72(1):59-60
pubmed: 29844150
Adv Physiol Educ. 2003 Dec;27(1-4):201-6
pubmed: 14627618
Physiol Rev. 2017 Oct 1;97(4):1469-1528
pubmed: 28931564
Am J Physiol. 1997 Oct;273(4):H1699-706
pubmed: 9362233
Hypertension. 2019 Jul;74(1):184-193
pubmed: 31154901
Circ Res. 1977 Jul;41(1):19-26
pubmed: 862138
Cell Rep. 2018 Oct 16;25(3):677-689.e4
pubmed: 30332647
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
J Hypertens. 2001 May;19(5):921-30
pubmed: 11393676
Cell Metab. 2019 Feb 5;29(2):362-382.e8
pubmed: 30344015
Hypertension. 2018 Nov;72(5):1125-1132
pubmed: 30354811
Curr Med Chem. 2012;19(10):1519-29
pubmed: 22360484
Physiology (Bethesda). 2017 May;32(3):224-233
pubmed: 28404738

Auteurs

Jonnelle M Edwards (JM)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Shaunak Roy (S)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Jeremy C Tomcho (JC)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Zachary J Schreckenberger (ZJ)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Saroj Chakraborty (S)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Nicole R Bearss (NR)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Piu Saha (P)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Cameron G McCarthy (CG)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Matam Vijay-Kumar (M)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Bina Joe (B)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.

Camilla F Wenceslau (CF)

Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA. Electronic address: Camilla.Wenceslau@utoledo.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH